Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon

American Journal of Surgery

Volumn 171, Issue 1, 1996, Pages 41-46

  Pricolo, Victor E ^a,c   Finkelstein, Sydney D ^b   Wu, Tsung Teh ^b   Keller, Gerald ^b   Bakker, Anke ^b   Swalsky, Patricia A ^b   Bland, Kirby I ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; COLON CARCINOMA; CONFERENCE PAPER; EXON; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0030043831     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)80071-3     Document Type: Conference Paper

References (26)

1. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. NEJM. 1988;319:525-532.
2. Albe X, Cassilakos P, Helfer-Guarnori K, et al. Independent prognostic value of ploidy in colorectal cancer: a prospective study using image cytometry. Cancer. 1990;66:1168-1175.
3. Giaretti W, Danova M, Geido E, et al. How cytometric DNA index in the prognosis of colorectal cancer. Cancer. 1991;67:1921-1927.
4. Venkatesh KS, Weingart DJ, Ramanujam PJ. Comparison of double and single parameters in DNA analysis for staging and as a prognostic indicator in patients with colon and rectal carcinoma. Dis Colon Rectum. 1994;37:1142-1147.
5. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. NEJM. 1994;331:213-221.
6. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology. 1992; 102:1136-1141.
7. Young J, Buttenshaw R, Butterworth L, et al. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. Oncogene. 1994;9:1053-1056.
8. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gostroenterology. 1993;104:57-64.
9. Bosari S, Viale G, Bossi P, et al. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator of colorectal adenocarcinomas. J Natl Cancer Inst. 1994;86:681-687.
10. Finkelstein SD, Sayegh R, Bakker A, Swalsky PA. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg. 1993;128:526-532.
11. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. NEJM. 1993;329:1318-1327.
12. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989;244: 217-221.
13. Meling GI, Lothe RA, Brresen AL, et al. The TP53 tumour suppressor gene in colorectal carcinomas - genetic alterations on chromosome 17. Br J Cancer. 1993;67:88-92.
14. Remvikos Y, Tominaga O, Hammel P, et al. Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer. 1992;66:758-764.
15. Boughdady AS, Kinsella AR, Haboubi NY, Schofield PF. K-ras gene mutations in colorectal adenomas and carcinomas from familial adenomatous polyposis patients. Surg Oncol. 1992;1:269-274.
16. McLellan AE, Owen RA, Stepniewska KA, et al. High frequency of K-ras mutations in sporadic colorectal adenomas. Gut. 1993;34: 392-396.
17. Vivona AA, Shpitz B, Medline A, et al. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane induced colon carcinogenesis. Carcinogenesis. 1993;14:1777-1781.
18. Chaubert P, Benhattar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol. 1994;144:767-775.
19. Muschel RJ, McKenna WG. Oncogenes and tumor progression. Cancer Res. 1989;9:1395-1406.
20. Mulder JW, Offerhaus GJ, de Feyter EP, et al. The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. Am J Pathol. 1992;141:797-804.
21. Weiner T, Cance WG. Molecular mechanisms involved in tumorigenesis and their surgical implications. Am J Surg. 1994;167: 428-434.
22. Losi L, Benhattar J, Costa J. Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer. 1992;28A:1115-1120.
23. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992;256:102-105.
24. Roth JA. Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment. Ann Surg Oncol. 1994;1:79-86.
25. McKenna WG, Weiss MC, Bakanauskas VJ, et al. The role of the H-ras oncogene in radiation resistance and metastasis. Int J Radiat Oncol Biol Phys. 1990;18:849-859.
26. Niimi S, Nagakawa K, Yokota J, et al. Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes. Br J Cancer. 1991;63:237-241.